JOHN C. REED - 15 Feb 2026 Form 4 Insider Report for JOHNSON & JOHNSON (JNJ)

Role
EVP, Innovative Medicine, R&D
Signature
/s/ Joleen Morgan, as attorney-in-fact for John C. Reed
Issuer symbol
JNJ
Transactions as of
15 Feb 2026
Net transactions value
-$5,224,221
Form type
4
Filing time
18 Feb 2026, 21:12:02 UTC
Previous filing
20 Oct 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
REED JOHN C EVP, Innovative Medicine, R&D ONE JOHNSON & JOHNSON PLAZA, NEW BRUNSWICK /s/ Joleen Morgan, as attorney-in-fact for John C. Reed 18 Feb 2026 0001181561

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction JNJ Common Stock Options Exercise $0 +1,349 +13% $0.000000 12,007 15 Feb 2026 Direct F1
transaction JNJ Common Stock Tax liability $93,728 -385 -3.2% $243.45 11,622 15 Feb 2026 Direct F2
transaction JNJ Common Stock Options Exercise $0 +1,847 +16% $0.000000 13,469 15 Feb 2026 Direct F3
transaction JNJ Common Stock Tax liability $128,542 -528 -3.9% $243.45 12,941 15 Feb 2026 Direct F2
transaction JNJ Common Stock Options Exercise $3,430,180 +21,721 +168% $157.92 34,662 17 Feb 2026 Direct
transaction JNJ Common Stock Sale $5,278,203 -21,721 -63% $243.00 12,941 17 Feb 2026 Direct
transaction JNJ Common Stock Options Exercise $4,673,101 +29,927 +231% $156.15 42,868 17 Feb 2026 Direct
transaction JNJ Common Stock Sale $7,272,261 -29,927 -70% $243.00 12,941 17 Feb 2026 Direct
transaction JNJ Common Stock Sale $554,769 -2,283 -18% $243.00 10,658 17 Feb 2026 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction JNJ Restricted Share Units Options Exercise $0 -1,349 -50% $0.000000 1,349 15 Feb 2026 Common Stock 1,349 Direct F1, F4
transaction JNJ Restricted Share Units Options Exercise $0 -1,847 -33% $0.000000 3,692 15 Feb 2026 Common Stock 1,847 Direct F3, F4
transaction JNJ Employee Stock Options (Right to Buy) Award $0 +49,382 $0.000000 49,382 15 Feb 2026 Common Stock 49,382 $243.45 Direct F5
transaction JNJ Restricted Share Units Award $0 +3,546 $0.000000 3,546 15 Feb 2026 Common Stock 3,546 Direct F4, F6
transaction JNJ Employee Stock Options (Right to Buy) Options Exercise $0 -21,721 -50% $0.000000 21,721 17 Feb 2026 Common Stock 21,721 $157.92 Direct F5
transaction JNJ Employee Stock Options (Right to Buy) Options Exercise $0 -29,927 -33% $0.000000 59,854 17 Feb 2026 Common Stock 29,927 $156.15 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2024 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSU convert into shares of Common Stock upon vesting.
F2 Shares withheld for payment of taxes upon vesting of RSUs.
F3 Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2025 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting on a one for one basis.
F4 Each RSU represents a contingent right to receive one share of Company Common Stock.
F5 Awarded under Issuer's Long-Term Incentive Plan. The Stock Option Award vests in three equal annual installments beginning on the first anniversary of the grant date.
F6 Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2026 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting on a one for one basis.